Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Anthem reverses course, agrees to cover Sarepta's Duchenne drug
Anthem reverses course, agrees to cover Sarepta's Duchenne drug
Anthem reverses course, agrees to cover Sarepta's Duchenne drug
Submitted by
admin
on November 13, 2017 - 8:46pm
Source:
BioPharma Dive
News Tags:
Anthem
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Exondys 51
Headline:
Anthem reverses course, agrees to cover Sarepta's Duchenne drug
Do Not Allow Advertisers to Use My Personal information
